These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1902339)

  • 1. Rh hemolytic disease of the newborn treated with high-dose intravenous immunoglobulin and plasmapheresis.
    Besalduch J; Forteza A; Durán MA; Reyero J; Caso M
    Transfusion; 1991 May; 31(4):380-1. PubMed ID: 1902339
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
    Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
    Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization.
    de la Cámara C; Arrieta R; González A; Iglesias E; Omeñaca F
    N Engl J Med; 1988 Feb; 318(8):519-20. PubMed ID: 3123931
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful management of a severe anti-M alloimmunization during pregnancy.
    Hubinont C; Delens G; Vanalbada De Haan Hettema J; Lambert C; Debauche C; Biard JM
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():175-176. PubMed ID: 28882462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.
    Berlin G; Selbing A; Gottvall T
    Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the use of plasmapheresis in the treatment of Rh incompatibility].
    Czeszyńska M; Cretti A; Rzechuła H; Malinowska-Szutowicz Z
    Acta Haematol Pol; 1988; 19(1-2):47-55. PubMed ID: 3149110
    [No Abstract]   [Full Text] [Related]  

  • 7. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?
    Chitkara U; Bussel J; Alvarez M; Lynch L; Meisel RL; Berkowitz RL
    Obstet Gynecol; 1990 Oct; 76(4):703-8. PubMed ID: 2120641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of the fetus with Rh incompatibility by the combined methods of plasmapheresis and intrauterine blood transfusion].
    Lozińska D; Radomska I; Samborska K; Dmoch E; Garwoliński J; Lenkiewicz B; Góralski T
    Pol Tyg Lek; 1988 Nov; 43(45):1449-51. PubMed ID: 3151013
    [No Abstract]   [Full Text] [Related]  

  • 10. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin.
    Berlin G; Selbing A; Ryden G
    Lancet; 1985 May; 1(8438):1153. PubMed ID: 2860352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of anti-Rh isoimmunization in pregnancy and hemolytic disease of the newborn].
    CUTRERA A
    Riv Ostet Ginecol; 1959 Nov; 14():780-9. PubMed ID: 13813457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
    Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
    Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose intravenous immunoglobulin therapy in the treatment of rhesus hemolytic disease.
    Aggarwal R; Seth R; Paul VK; Deorari AK
    J Trop Pediatr; 2002 Apr; 48(2):116-7. PubMed ID: 12022426
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 20. [Perinatal hemolytic disease caused by anti-c. A clinical case].
    Donoso Siña E; Herrera Gonzalez B; González Bruzzone P; Cuellar Castañón A
    Rev Chil Obstet Ginecol; 1983; 48(3):175-9. PubMed ID: 6442780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.